Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review

source extracted confidence: high 2026-04-09
#dietary-supplements #fatty-acids-omega-3 #female #fish-oils #humans

Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review

AlAmmar et al., 2021 | Nutr Neurosci | Systematic Review

Citation

AlAmmar Welayah Ali, Albeesh Fatima Hassan, ... Khattab Rabie Yousif. Effect of omega-3 fatty acids and fish oil supplementation on multiple sclerosis: a systematic review. Nutr Neurosci. 2021-Jul;24(7):569-579. doi:10.1080/1028415X.2019.1659560

Abstract

Background: Multiple sclerosis (MS) is an autoimmune disease that affects the central nervous system, resulting in the degradation of the myelin sheath. Diet especially fish oils and omega-3 has been found to play an important role in MS. This work aimed to review the literature systematically for evidence on the effect of omega-3 fatty acids (EPA, DPA and DHA) on MS progression in adults.Methods: The literature search was conducted in PubMed, Oxford, Cochrane, Embase, International pharmaceutical abstract, PsychINFO, and clinical trials government. The inclusions were studies performed on humans both male and female, aged 18 years at minimum, diagnosed with MS according to McDonald 2010 criteria. Otherwise, all studies were excluded.Results: A total of 5554 studies were screened and seven were thoroughly focused on as they typically met the inclusion criteria. These studies showed the beneficial roles of fish oil supplementation and omega-3 fatty acids in improving the quality of life of MS patients. These roles were attributed to their beneficial effects on inflammatory markers, glutathione reductase, reducing the relapsing rate, and achieving balanced omega-6 to omega-3 ratios.Conclusion: Omega-3 and fish oils supplementations have beneficial effects on reducing the relapsing rate, inflammatory markers, and improving the quality of life for MS patients.

Key Findings

A total of 5554 studies were screened and seven were thoroughly focused on as they typically met the inclusion criteria. These studies showed the beneficial roles of fish oil supplementation and omega-3 fatty acids in improving the quality of life of MS patients. These roles were attributed to their beneficial effects on inflammatory markers, glutathione reductase, reducing the relapsing rate, and achieving balanced omega-6 to omega-3 ratios.Conclusion: Omega-3 and fish oils supplementations hav

Outcomes Measured

  • inflammatory markers

Population

Field Value
Population See abstract
Sample Size 5554
Age Range See abstract
Condition See abstract

MeSH Terms

  • Dietary Supplements
  • Fatty Acids, Omega-3
  • Female
  • Fish Oils
  • Humans
  • Male
  • Multiple Sclerosis

Evidence Classification

  • Level: Systematic Review
  • Publication Types: Journal Article, Systematic Review
  • Vertical: omega-3

Provenance

Source extracted via PubMed E-utilities API on 2026-04-09